ALLK Company Profile and Key Details

Q: Who are the executives of ALLK?

Mr. Scott Hirsch M.B.A.Chief Operating OfficerBrad YoungbloodHead of ResearchDr. Adam L. Tomasi Ph.D.PresDr. Robert Alexander Ph.D.Chief Executive Officer & DirectorDr. Henrik Sandvad RasmussenStrategic AdvisorMr. Baird Radford IIIChief Financial OfficerDr. Craig Paterson M.D.Chief Medical OfficerMs. Mary Cromwell Ph.D.Chief Technical OfficerDr. Henrik Sandvad Rasmussen M.D., Ph.D.Strategic AdvisorDr. Brad Youngblood Ph.D.Head of Research & Pre-Clinical Devel.Mr. Alan ChangDirector of Medical Affairs & Data Analytics

NASDAQ : ALLK

Allakos

$0.33

0.0007+0.22%

At Close 4:00 PM

Not Actively Trading

64.45

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Allakos Inc. (ALLK) stock surged +0.22%, trading at $0.33 on NASDAQ, up from the previous close of $0.33. The stock opened at $0.33, fluctuating between $0.33 and $0.33 in the recent session.

Stock Snapshot

0.3291

Prev. Close

29.74M

Market Cap

0.3291

Day Low

-0.4219230769230769

P/E Ratio

-0.78

EPS (TTM)

-1.34

Cash Flow per Share

0.33

Open

90.38M

Number of Shares

0.3291

Day High

63.89%

Free Float in %

1.93

Book Value

1.31M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 14, 2025	0.33	0.33	0.33	0.33	724.8K
May 13, 2025	0.33	0.33	0.33	0.33	438.09K
May 12, 2025	0.33	0.33	0.33	0.33	631.97K
May 09, 2025	0.33	0.33	0.33	0.33	153.57K
May 08, 2025	0.33	0.33	0.33	0.33	331.49K
May 07, 2025	0.33	0.33	0.33	0.33	380.73K
May 06, 2025	0.33	0.33	0.33	0.33	632.42K
May 05, 2025	0.33	0.33	0.33	0.33	409.81K
May 02, 2025	0.32	0.33	0.32	0.33	796.15K
May 01, 2025	0.33	0.33	0.33	0.33	768.9K
Apr 30, 2025	0.33	0.33	0.32	0.33	973.18K
Apr 29, 2025	0.33	0.33	0.33	0.33	197.49K
Apr 28, 2025	0.33	0.33	0.33	0.33	310.21K
Apr 25, 2025	0.33	0.33	0.33	0.33	212.36K
Apr 24, 2025	0.33	0.33	0.33	0.33	125.91K
Apr 23, 2025	0.33	0.33	0.33	0.33	129.35K
Apr 22, 2025	0.33	0.33	0.33	0.33	851.69K
Apr 21, 2025	0.32	0.33	0.32	0.33	580.55K
Apr 17, 2025	0.32	0.33	0.32	0.33	1.93M
Apr 16, 2025	0.32	0.32	0.32	0.32	337.12K

Contact Details

San Carlos, CA 94065

United States

https://www.allakos.com 650 597 5002

About Company

Allakos Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing therapeutic agents. These treatments are designed to target specific immunomodulatory receptors on immune effector cells, addressing a spectrum of allergic, inflammatory, and proliferative conditions. The company's flagship investigational product is lirentelimab (AK002), a monoclonal antibody. This compound is currently undergoing a pivotal Phase III clinical trial for eosinophilic gastritis and/or duodenitis. It is also being evaluated in a Phase II/III study for eosinophilic esophagitis, and a Phase II trial for atopic dermatitis and chronic spontaneous urticaria. Furthermore, Allakos is exploring lirentelimab (AK002) for potential use in mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. In parallel, their pipeline includes AK006, another candidate being developed to tackle various allergic and inflammatory diseases. Established in 2012, Allakos Inc. operates from its headquarters located in Redwood City, California.

Stock Peers

ARGX

0.35+0.04%

argenx SE$984.39 REGN

-11.77-1.48%

Regeneron Pharmaceuticals, Inc.$781.49 MDGL

1.37+0.26%

Madrigal Pharmaceuticals, Inc.$534.49 VRTX

0.88+0.17%

Vertex Pharmaceuticals Incorporated$515.44 UTHR

-6.75-1.34%

United Therapeutics Corporation$497.11 KRYS

1.45+0.42%

Krystal Biotech, Inc.$347.00 ONC

4.71+1.38%

BeOne Medicines AG$346.51 PRAX

-3.99-1.18%

Praxis Precision Medicines, Inc.$334.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-4.78-1.65%

Ligand Pharmaceuticals Incorporated$284.47

Frequently Asked Questions

What is the current Allakos Inc. (ALLK) stock price?

Allakos Inc. (NASDAQ: ALLK) stock price is $0.33 in the last trading session. During the trading session, ALLK stock reached the peak price of $0.33 while $0.33 was the lowest point it dropped to. The percentage change in ALLK stock occurred in the recent session was 0.22% while the dollar amount for the price change in ALLK stock was $0.00.

ALLK's industry and sector of operation?

The NASDAQ listed ALLK is part of Biotechnology industry that operates in the broader Healthcare sector. Allakos Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ALLK?

Mr. Scott Hirsch M.B.A.
Chief Operating Officer
Brad Youngblood
Head of Research
Dr. Adam L. Tomasi Ph.D.
Pres
Dr. Robert Alexander Ph.D.
Chief Executive Officer & Director
Dr. Henrik Sandvad Rasmussen
Strategic Advisor
Mr. Baird Radford III
Chief Financial Officer
Dr. Craig Paterson M.D.
Chief Medical Officer
Ms. Mary Cromwell Ph.D.
Chief Technical Officer
Dr. Henrik Sandvad Rasmussen M.D., Ph.D.
Strategic Advisor
Dr. Brad Youngblood Ph.D.
Head of Research & Pre-Clinical Devel.
Mr. Alan Chang
Director of Medical Affairs & Data Analytics

How ALLK did perform over past 52-week?

ALLK's closing price is 49.59% higher than its 52-week low of $0.22 where as its distance from 52-week high of $1.56 is -78.9%.

How many employees does ALLK have?

Number of ALLK employees currently stands at 131.

Link for ALLK official website?

Official Website of ALLK is: https://www.allakos.com

How do I contact ALLK?

ALLK could be contacted at phone 650 597 5002 and can also be accessed through its website. ALLK operates from 975 Island Drive, San Carlos, CA 94065, United States.

How many shares of ALLK are traded daily?

ALLK stock volume for the day was 1.31M shares. The average number of ALLK shares traded daily for last 3 months was 2.85M.

What is the market cap of ALLK currently?

The market value of ALLK currently stands at $29.74M with its latest stock price at $0.33 and 90.38M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	131
Beta	0.14
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	131
Beta	0.14
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ALLK Company Profile and Key Details

Allakos

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Company Overview

Dividend & Fair Value

Valuation Metrics

Key Takeaways

Price Forecast & Outlook